Cor Lieftink

6PUBLICATIONS
99CO-AUTHORS
Medical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Medical virologyMolecular targetsCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma.

Alaa Embaby, Sanne C F A Huijberts, Liqin Wang

|Mar 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.

Matheus Henrique Dias, Anoek Friskes, Siying Wang

|Feb 08, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.

Esmée P Hoefsmit, Paula T van Royen, Disha Rao

|Oct 05, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.

Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen

Pageof 1

Frequent Collaborators

5 joint publications

Roderick L Beijersbergen

3 joint publications

René Bernards

2 joint publications

Christian U Blank

2 joint publications

Liesbeth Hoekman